000			01992 a2200517 4500
005			20250514005056.0
264		0	_c20011004
008			200110s 0 0 eng d
022			_a0735-1097
024	7		_a10.1016/s0735-1097(01)01404-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aWittstein, I S
245	0	0	_aCardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy. _h[electronic resource]
260			_bJournal of the American College of Cardiology _cAug 2001
300			_a429-35 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdrenergic beta-Antagonists _xpharmacology
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCardiomyopathy, Dilated _xmetabolism
650	0	4	_aCompliance
650	0	4	_aDepression, Chemical
650	0	4	_aDiastole
650	0	4	_aDobutamine _xpharmacology
650	0	4	_aEnalaprilat _xpharmacology
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFemale
650	0	4	_aHeart _xphysiopathology
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHumans
650	0	4	_aLosartan _xpharmacology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Contraction _xdrug effects
650	0	4	_aMyocardium _xmetabolism
650	0	4	_aNitric Oxide _xbiosynthesis
650	0	4	_aVentricular Dysfunction, Left _xmetabolism
650	0	4	_aomega-N-Methylarginine _xpharmacology
700	1		_aKass, D A
700	1		_aPak, P H
700	1		_aMaughan, W L
700	1		_aFetics, B
700	1		_aHare, J M
773	0		_tJournal of the American College of Cardiology _gvol. 38 _gno. 2 _gp. 429-35
856	4	0	_uhttps://doi.org/10.1016/s0735-1097(01)01404-8 _zAvailable from publisher's website
999			_c11424960 _d11424960